Literature DB >> 23706818

Processing-independent CRISPR RNAs limit natural transformation in Neisseria meningitidis.

Yan Zhang1, Nadja Heidrich, Biju Joseph Ampattu, Carl W Gunderson, H Steven Seifert, Christoph Schoen, Jörg Vogel, Erik J Sontheimer.   

Abstract

CRISPR interference confers adaptive, sequence-based immunity against viruses and plasmids and is specified by CRISPR RNAs (crRNAs) that are transcribed and processed from spacer-repeat units. Pre-crRNA processing is essential for CRISPR interference in all systems studied thus far. Here, our studies of crRNA biogenesis and CRISPR interference in naturally competent Neisseria spp. reveal a unique crRNA maturation pathway in which crRNAs are transcribed from promoters that are embedded within each repeat, yielding crRNA 5' ends formed by transcription and not by processing. Although crRNA 3' end formation involves RNase III and trans-encoded tracrRNA, as in other type II CRISPR systems, this processing is dispensable for interference. The meningococcal pathway is the most streamlined CRISPR/Cas system characterized to date. Endogenous CRISPR spacers limit natural transformation, which is the primary source of genetic variation that contributes to immune evasion, antibiotic resistance, and virulence in the human pathogen N. meningitidis.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23706818      PMCID: PMC3694421          DOI: 10.1016/j.molcel.2013.05.001

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  82 in total

Review 1.  Recombination and the population structures of bacterial pathogens.

Authors:  E J Feil; B G Spratt
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

2.  Genomic content of Neisseria species.

Authors:  Deborah M Tobiason; H Steven Seifert
Journal:  J Bacteriol       Date:  2010-02-19       Impact factor: 3.490

3.  CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA.

Authors:  Luciano A Marraffini; Erik J Sontheimer
Journal:  Science       Date:  2008-12-19       Impact factor: 47.728

4.  Phage response to CRISPR-encoded resistance in Streptococcus thermophilus.

Authors:  Hélène Deveau; Rodolphe Barrangou; Josiane E Garneau; Jessica Labonté; Christophe Fremaux; Patrick Boyaval; Dennis A Romero; Philippe Horvath; Sylvain Moineau
Journal:  J Bacteriol       Date:  2007-12-07       Impact factor: 3.490

5.  Sequence- and structure-specific RNA processing by a CRISPR endonuclease.

Authors:  Rachel E Haurwitz; Martin Jinek; Blake Wiedenheft; Kaihong Zhou; Jennifer A Doudna
Journal:  Science       Date:  2010-09-10       Impact factor: 47.728

6.  Virulence evolution of the human pathogen Neisseria meningitidis by recombination in the core and accessory genome.

Authors:  Biju Joseph; Roland F Schwarz; Burkhard Linke; Jochen Blom; Anke Becker; Heike Claus; Alexander Goesmann; Matthias Frosch; Tobias Müller; Ulrich Vogel; Christoph Schoen
Journal:  PLoS One       Date:  2011-04-26       Impact factor: 3.240

7.  CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III.

Authors:  Elitza Deltcheva; Krzysztof Chylinski; Cynthia M Sharma; Karine Gonzales; Yanjie Chao; Zaid A Pirzada; Maria R Eckert; Jörg Vogel; Emmanuelle Charpentier
Journal:  Nature       Date:  2011-03-31       Impact factor: 49.962

8.  Transcription initiation by mix and match elements: flexibility for polymerase binding to bacterial promoters.

Authors:  India G Hook-Barnard; Deborah M Hinton
Journal:  Gene Regul Syst Bio       Date:  2007

9.  Fuzzy species among recombinogenic bacteria.

Authors:  William P Hanage; Christophe Fraser; Brian G Spratt
Journal:  BMC Biol       Date:  2005-03-07       Impact factor: 7.431

10.  RNA-guided editing of bacterial genomes using CRISPR-Cas systems.

Authors:  Wenyan Jiang; David Bikard; David Cox; Feng Zhang; Luciano A Marraffini
Journal:  Nat Biotechnol       Date:  2013-01-29       Impact factor: 54.908

View more
  117 in total

Review 1.  CRISPR-Cas immunity in prokaryotes.

Authors:  Luciano A Marraffini
Journal:  Nature       Date:  2015-10-01       Impact factor: 49.962

2.  Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system.

Authors:  Bernd Zetsche; Jonathan S Gootenberg; Omar O Abudayyeh; Ian M Slaymaker; Kira S Makarova; Patrick Essletzbichler; Sara E Volz; Julia Joung; John van der Oost; Aviv Regev; Eugene V Koonin; Feng Zhang
Journal:  Cell       Date:  2015-09-25       Impact factor: 41.582

Review 3.  Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery.

Authors:  Mehmet Fatih Bolukbasi; Ankit Gupta; Scot A Wolfe
Journal:  Nat Methods       Date:  2016-01       Impact factor: 28.547

4.  Target specificity of the CRISPR-Cas9 system.

Authors:  Xuebing Wu; Andrea J Kriz; Phillip A Sharp
Journal:  Quant Biol       Date:  2014-06

5.  Biochemical characterization of RNA-guided ribonuclease activities for CRISPR-Cas9 systems.

Authors:  Max J Gramelspacher; Zhonggang Hou; Yan Zhang
Journal:  Methods       Date:  2019-06-20       Impact factor: 3.608

Review 6.  Cas9-based tools for targeted genome editing and transcriptional control.

Authors:  Tao Xu; Yongchao Li; Joy D Van Nostrand; Zhili He; Jizhong Zhou
Journal:  Appl Environ Microbiol       Date:  2014-01-03       Impact factor: 4.792

7.  CRISPRs extending their reach: prokaryotic RNAi protein Cas9 recruited for gene regulation.

Authors:  Nadja Heidrich; Jörg Vogel
Journal:  EMBO J       Date:  2013-06-11       Impact factor: 11.598

Review 8.  CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity.

Authors:  Rodolphe Barrangou; Luciano A Marraffini
Journal:  Mol Cell       Date:  2014-04-24       Impact factor: 17.970

9.  Role of the Streptococcus mutans CRISPR-Cas systems in immunity and cell physiology.

Authors:  M A Serbanescu; M Cordova; K Krastel; R Flick; N Beloglazova; A Latos; A F Yakunin; D B Senadheera; D G Cvitkovitch
Journal:  J Bacteriol       Date:  2014-12-08       Impact factor: 3.490

Review 10.  Adapting to new threats: the generation of memory by CRISPR-Cas immune systems.

Authors:  Robert Heler; Luciano A Marraffini; David Bikard
Journal:  Mol Microbiol       Date:  2014-06-04       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.